Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Epizyme Inc Plans To Raise $60 Million Through IPO-AP


Monday, 27 May 2013 10:12am EDT 

The Associated Press reported that Epizyme Inc plans to raise $60 million by offering 4.3 million shares at a price range of $13.00 to $15.00. At the midpoint of the proposed range, Epizyme would command a market value of $375 million. Epizyme, which was founded in 2007, booked $48 million in sales over the last 12 months. The Cambridge, MA-based company plans to list on the NASDAQ under the symbol EPZM. Citi (C), Cowen & Company and Leerink Swann are the joint bookrunners on the deal. 

Company Quote

26.64
-0.47 -1.73%
4:00pm EDT